We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.55B
AUM Growth
-$472M
Cap. Flow
-$301M
Cap. Flow %
-3.99%
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$25.4M
2
ABBV icon
AbbVie
ABBV
+$21.9M
3
KYNB
Kyntra Bio
KYNB
+$19.2M
4
WM icon
Waste Management
WM
+$19M
5
GILD icon
Gilead Sciences
GILD
+$17.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$70.2M
2
ARRY
Array Biopharma Inc
ARRY
+$45.8M
3
BIIB icon
Biogen
BIIB
+$43.3M
4
META icon
Meta Platforms (Facebook)
META
+$24.8M
5
AMGN icon
Amgen
AMGN
+$21.7M

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Technology 18.27%
3 Financials 10.05%
4 Consumer Discretionary 9.39%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JKHY icon
751
Jack Henry & Associates
JKHY
$10.8B
– –
-13
Closed -$1.74M
JWN
752
DELISTED
Nordstrom
JWN
– –
-22,939
Closed -$728K
KT icon
753
KT
KT
$8.87B
– –
-26,525
Closed -$327K
LGND icon
754
Ligand Pharmaceuticals
LGND
$6.07B
– –
-24,045
Closed -$1.71M
LSTR icon
755
Landstar System
LSTR
$6.68B
– –
-4,000
Closed -$430K
MAN icon
756
ManpowerGroup
MAN
$2.44B
– –
-11
Closed -$1.06M
MCY icon
757
Mercury Insurance
MCY
$5.99B
– –
-8,000
Closed -$498K
MDT icon
758
Medtronic
MDT
$108B
– –
-5
Closed -$487K
MPWR icon
759
Monolithic Power Systems
MPWR
$66.6B
– –
-14,084
Closed -$1.9M
MPT
760
Medical Properties Trust
MPT
$2.92B
– –
-26,000
Closed -$451K
MSA icon
761
Mine Safety
MSA
$6.82B
– –
-4,000
Closed -$420K
NCLH icon
762
Norwegian Cruise Line
NCLH
$9.2B
– –
-113,444
Closed -$6.06M
NDSN icon
763
Nordson
NDSN
$16.6B
– –
-3,000
Closed -$422K
NKE icon
764
CALL
Nike
NKE
$61.9B
– –
-149,872
Closed -$12.5M
NOAH
765
Noah Holdings
NOAH
$593M
– –
-151,000
Closed -$6.4M
NVO
766
Novo Nordisk
NVO
$218B
– –
-84
Closed -$2.14M
NYT icon
767
New York Times
NYT
$11.8B
– –
-14,000
Closed -$455K
OHI icon
768
Omega Healthcare
OHI
$15.3B
– –
-13,000
Closed -$476K
PARA
769
DELISTED
Paramount Global Class B
PARA
– –
-187,201
Closed -$9.3M
PNR icon
770
Pentair
PNR
$10.4B
– –
-34
Closed -$1.26M
RGLD icon
771
Royal Gold
RGLD
$17.2B
– –
-8,628
Closed -$880K
RYN icon
772
Rayonier
RYN
$6.56B
– –
-16,533
Closed -$453K
SAN icon
773
Banco Santander
SAN
$201B
– –
-818
Closed -$3.59M
SBRA icon
774
Sabra Healthcare REIT
SBRA
$5.64B
– –
-24,000
Closed -$470K
SEIC icon
775
SEI Investments
SEIC
$12B
– –
-21
Closed -$1.18M
29 30
31
32 33

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2019 Portfolio in Review

As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.

  • Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
  • Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
  • Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
  • Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
  • Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
  • Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
  • Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.